Lower incidence of biliary carcinoma in patients with primary sclerosing cholangitis and high serum levels of immunoglobulin E

Clinical Gastroenterology and Hepatology

Volumn 10, Issue 1, 2012, Pages 79-83

  Hirano, Kenji ^a   Tada, Minoru ^a   Mizuno, Suguru ^a   Isayama, Hiroyuki ^a   Takahara, Naminatsu ^a   Nagano, Rie ^a   Hamada, Tsuyoshi ^a   Miyabayashi, Koji ^a   Ito, Yukiko ^a   Mohri, Dai ^a   Kawakubo, Kazumichi ^a   Sasaki, Takashi ^a   Kogure, Hirofumi ^a   Yamamoto, Natsuyo ^a   Sasahira, Naoki ^a   Yamashiki, Noriyo ^b   Sugawara, Yasuhiko ^b   Kokudo, Norihiro ^b   Toda, Nobuo ^c   Koike, Kazuhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c MITSUI MEMORIAL HOSPITAL   (Japan)

Author keywords

Allergy; Malignancy; Prognosis; Ulcerative Colitis

Indexed keywords

BILIRUBIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN M; SERUM ALBUMIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; ASTHMA; ATOPIC DERMATITIS; BILE DUCT CARCINOMA; BILIRUBIN BLOOD LEVEL; CANCER INCIDENCE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG HYPERSENSITIVITY; ENTERITIS; EOSINOPHILIA; FEMALE; FOLLOW UP; GALLBLADDER CARCINOMA; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MORTALITY; ONSET AGE; PRIMARY SCLEROSING CHOLANGITIS; PROGNOSIS;

ADOLESCENT; ADULT; AGED; BILIARY TRACT NEOPLASMS; CARCINOMA; CHILD; CHOLANGITIS, SCLEROSING; FEMALE; HUMANS; IMMUNOGLOBULIN E; INCIDENCE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 83855165648     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2011.09.015     Document Type: Article

References (29)

1. Talwalkar J.A., Lindor K.D. Primary sclerosing cholangitis. Inflamm Bowel Dis 2005, 11:62-72.
2. Takikawa H., Takamori Y., Tanaka A., et al. Analysis of 388 cases of primary sclerosing cholangitis in Japan; presence of a subgroup without pancreatic involvement in older patients. Hepatol Res 2004, 29:153-159.
3. Hirano K., Tada M., Isayama H., et al. Clinical features of primary sclerosing cholangitis with onset age above 50 years. J Gastroenterol 2008, 43:729-733.
4. Turner M.C., Chen Y., Krewski D., et al. An overview of the association between allergy and cancer. Int J Cancer 2006, 118:3124-3132.
5. Wiemels J.L., Wiencke J.K., Patoka J., et al. Reduced immunoglobulin E and allergy among adults with glioma compared with controls. Cancer Res 2004, 64:8468-8473.
6. Wrensch M., Wiencke J.K., Wiemels J., et al. Serum IgE, tumor epidermal growth factor receptor expression, and inherited polymorphisms associated with glioma survival. Cancer Res 2006, 66:4531-4541.
7. Mir-Madjlessi S.H., Farmer R.G., Sivak M.V. Bile duct carcinoma in patients with ulcerative colitis. Relationship to sclerosing cholangitis: report of six cases and review of the literature. Dig Dis Sci 1987, 32:145-154.
8. Lewis J.T., Talwalkar J.A., Rosen C.B., et al. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence. Am J Surg Pathol 2007, 31:907-913.
9. Buckles D.C., Lindor K.D., Larusso N.F., et al. In primary sclerosing cholangitis, gallbladder polyps are frequently malignant. Am J Gastroenterol 2002, 97:1138-1142.
10. Said K., Glaumann H., Bergquist A. Gallbladder disease in patients with primary sclerosing cholangitis. J Hepatol 2008, 48:598-605.
11. Lindor K.D., LaRusso N.F. Primary sclerosing cholangitis. Schiff's diseases of the liver 2003, 673-684. Lippincott Williams & Wilkins, Philadelphia. 9th ed.
12. Shimazu S., Enomoto T. Serum IgE levels in healthy children. Allergy Immunol 1996, 2:62-67. (Japanese, English abstr).
13. Kaneko Y., Motohashi Y., Nakamura H., et al. Increasing prevalence of Japanese cedar pollinosis: a meta-regression analysis. Int Arch Allergy Immunol 2005, 136:365-371.
14. Helzberg J.H., Petersen J.M., Boyer J.L. Improved survival with primary sclerosing cholangitis. A review of clinicopathologic features and comparison of symptomatic and asymptomatic patients. Gastroenterology 1987, 92:1869-1875.
15. Burak K., Angulo P., Pasha T.M., et al. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol 2004, 99:523-526.
16. Broomé U., Olsson R., Lööf L., et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996, 38:610-615.
17. Rosen C.B., Nagorney D.M., Wiesner R.H., et al. Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg 1991, 213:21-25.
18. Miros M., Kerlin P., Walker N., et al. Predicting cholangiocarcinoma in patients with primary sclerosing cholangitis before transplantation. Gut 1991, 32:1369-1373.
19. Karagiannis S.N., Wang Q., East N., et al. Activity of human monocytes in IgE antibody-dependent surveillance and killing of ovarian tumor cells. Eur J Immunol 2003, 33:1030-1040.
20. Fu S.L., Pierre J., Smith-Norowitz T.A., et al. Immunoglobulin E antibodies from pancreatic cancer patients mediate antibody-dependent cell-mediated cytotoxicity against pancreatic cancer cells. Clin Exp Immunol 2008, 153:401-409.
21. Karagiannis S.N., Bracher M.G., Beavil R.L., et al. Role of IgE receptors in IgE antibody-dependent cytotoxicity and phagocytosis of ovarian tumor cells by human monocytic cells. Cancer Immunol Immunother 2008, 57:247-263.
22. Kusaka Y., Sato K., Zhang Q., et al. Association of natural killer cell activity with serum IgE. Int Arch Allergy Immunol 1997, 112:331-335.
23. Imai K., Matsuyama S., Miyake S., et al. Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet 2000, 356:1795-1799.
24. Di Lorenzo G., Pacor M.L., Esposito Pellitteri M., et al. A study of age-related IgE pathophysiological changes. Mech Ageing Dev 2003, 124:445-448.
25. Okazaki K., Uchida K., Koyabu M., et al. Recent advances in the concept and diagnosis of autoimmune pancreatitis and IgG4-related disease. J Gastroenterol 2011, 46:277-288.
26. Aalberse R.C., Stapel S.O., Schuurman J., et al. Immunoglobulin G4: an odd antibody. Clin Exp Allergy 2009, 39:469-477.
27. Boberg K.M., Bergquist A., Mitchell S., et al. Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation. Scand J Gastroenterol 2002, 37:1205-1211.
28. Bergquist A., Glaumann H., Persson B., et al. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study. Hepatology 1998, 27:311-316.
29. Chalasani N., Baluyut A., Ismail A., et al. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study. Hepatology 2000, 31:7-11.